Attività Correnti Cambiamento Data
Adma Biologics USD 528.2M 17.03M 2026-06
Alnylam Pharmaceuticals USD 4.62B 400.86M 2026-06
BioCryst Pharmaceuticals USD 484.68M 111.06M 2026-06
Minerva Neurosciences USD 83.1M 70.08M 2025-12
Novavax USD 771.1M 79.72M 2026-06
Omeros USD 69.65M 26.53M 2025-06
Takeda JPY 3.15T 59.77B 2026-06